Recently, for instance, an adenoviral overexpression of Atrogin-1 and MuRF1 E3 ligases suppresses the cardiac hypertrophy induced by phenylephrine treatment (Wertz et al., 2004; Maejima et al., 2014). Here, FBXO32 is linked to cardiac hypertrophy.